GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat diabetes may be effective in reducing alcohol use.

With obesity rates soaring, many experts have been lobbying for better regulation of the US ‘industrial food complex’ for ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

The FDA has cleared the research organization's investigational new drug application, allowing it to start clinical tests of the experimental treatment DT2-SCT.

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

A recent study from the University of Hong Kong has found that sodium-glucose cotransporter 2 inhibitors (SGLT2i), a new type ...